Cadila slumps after Citi downgrade

Tags: Companies
Shares of Cadila Healthcare fall around 10 percent after Citigroup downgrades them to "sell" from "buy".

Citi says Cadila's valuations "have moved well ahead of fundamentals," despite gradual recovery in the sector and improving US business.

Prefers Aurobindo Pharma and Glenmark Pharmaceuticals in midcaps among drugmakers.

EDITORIAL OF THE DAY

  • CAG's observations on auction of coal blocks must be investigated by CVC

    Coal has an intrinsic relationship with fire.

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Urs Schoettli

Look, who's blowing his own Trump(et)

Traditionally, major political events in the United States are followed ...

Zehra Naqvi

Deliciously desi

What’s the best way to spend a chilled-out weekend all ...

Bubbles Sabharwal

Good or bad, say thanks to the universe

It is true, life is richer than fiction. If we ...